STAT1 and pancreatic neoplasm: For example, Liu et al. showed that the phosphorylated STAT1 could directly interact with the promotor of FOXM1 thus downregulating its expression, finally enhancing the sensitivity of pancreatic cancer cells to gemcitabine [25, 26].